Dr. Loreen Herwaldt, MD
Claim this profileClinical Trials Loreen Herwaldt, MD is currently running
More about Loreen Herwaldt, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Loreen Herwaldt, MD has experience with
- Povidone-Iodine Topical Ointment
Breakdown of trials Loreen Herwaldt, MD has run
Wound Infection
Surgical Site Infection
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Loreen Herwaldt, MD specialize in?
Loreen Herwaldt, MD focuses on Wound Infection and Surgical Site Infection. In particular, much of their work with Wound Infection has involved treating patients, or patients who are undergoing treatment.
Is Loreen Herwaldt, MD currently recruiting for clinical trials?
Yes, Loreen Herwaldt, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Loreen Herwaldt, MD has studied deeply?
Yes, Loreen Herwaldt, MD has studied treatments such as Povidone-Iodine Topical Ointment.
What is the best way to schedule an appointment with Loreen Herwaldt, MD?
Apply for one of the trials that Loreen Herwaldt, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.